The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kolokolov O.V.

Razumovsky Saratov State Medical University

Salina E.A.

Razumovsky Saratov State Medical University

Yudina V.V.

Razumovsky Saratov State Medical University

Shuldyakov A.A.

Razumovsky Saratov State Medical University

Runnova A.E.

Razumovsky Saratov State Medical University

Infections, pandemics and sleep disorders

Authors:

Kolokolov O.V., Salina E.A., Yudina V.V., Shuldyakov A.A., Runnova A.E.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(4‑2): 68‑74

DOI: 10.17116/jnevro202112104268

Read: 5041 times

Download PDF (RU)
Contact the author
Table of contents

INFECTIONS, PANDEMICS AND SLEEP DISORDERS
INFECTIONS, PANDEMICS AND SLEEP DISORDERS

To cite this article:

Kolokolov OV, Salina EA, Yudina VV, Shuldyakov AA, Runnova AE. Infections, pandemics and sleep disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(4‑2):68‑74. (In Russ.)
https://doi.org/10.17116/jnevro202112104268

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Factors of depression acco­rding to acti­graphy in the fall season. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):27-32
Inso­mnia in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):46-51
The use of zolpidem in the treatment of acute and chro­nic inso­mnia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):52-56
The pote­ntial of neurofeedback control in treating inso­mnia and improving sleep quality (a systematic review). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):57-63
Effe­cts of rhythmic transcranial magnetic stimulation in the treatment of inso­mnia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):64-69
Infe­ctious diseases of the respiratory system in Irku­tsk in 2023 acco­rding to auto­psy data. Russian Journal of Archive of Pathology. 2025;(2):37-42
Post-Covid aortitis with cardiac invo­lvement: progressive aortic aneurysm combined with active myocarditis. Russian Journal of Archive of Pathology. 2025;(2):53-58
Prediction and prevention of burnout syndrome in health care professionals in high epidemic risk settings. Russian Journal of Preventive Medi­cine. 2025;(4):51-56
Impact of the COVID-19 epidemic on students’ health. Part II. Features of hemo­dynamics, vege­tative regu­lation, resu­lts of psychological and stress resi­stance testing among students depe­nding on the COVID-19 presence in their medi­cal history. Russian Journal of Preventive Medi­cine. 2025;(4):94-101
The state of mental health of migrant workers and citi­zens of the Russian Fede­ration: A comparative analysis as illu­strated by the Moscow region. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):95-101
Abstract:

The study of neurological symptoms and signs connected with acute and long-term periods of infectious diseases is relevant during pandemics. The COVID-19 pandemic has increased the number of patients suffering from insomnia. Sleep disturbance is an unfavorable prognostic factor for infections. Risk factors and mechanisms of sleep disturbance, their relationship with inflammation and dysfunction of the immune system in infectious diseases are presented. In particular, dysfunction of the melatonergic system as the cause of insomnia during pandemics is considered. The authors highlight the relevance of measures aimed at the rehabilitation of patients, in particular, the use of sonnovan to restore normal sleep, which is important for a person’s mental and physical health.

Keywords:

sleep disorders
insomnia
pandemic
infection
COVID-19
SARS-CoV-2
anxiety
depression
melatonin
sonnovan

Authors:

Kolokolov O.V.

Razumovsky Saratov State Medical University

Salina E.A.

Razumovsky Saratov State Medical University

Yudina V.V.

Razumovsky Saratov State Medical University

Shuldyakov A.A.

Razumovsky Saratov State Medical University

Runnova A.E.

Razumovsky Saratov State Medical University

Received:

06.04.2021

Accepted:

28.04.2021

Close metadata

References:

  1. The National Center for Biotechnology Information. National Library of Medicine. PubMed [Electronic resource]. Access date 25.02.2021. https://pubmed.ncbi.nlm. nih.gov
  2. Poluéktov MG. Sleep and neuroplasticity. S.S. Korsakov Journal of Neurology and Psychiatry (Special Issues). 2019;119(4-2):7-7. (In Russ.). https://doi.org/10.17116/jnevro20191190427
  3. Kovalzon VM. The nature of sleep. Priroda. 1999;8:172-179. (In Russ.).
  4. Limousin N, Dehais C, Gout O, Héran F, Oudiette D, Arnulf I. A brainstem inflammatory lesion causing REM sleep behavior disorder and sleepwalking (parasomnia overlap disorder). Sleep Med. 2009;10(9):1059-1062. https://doi.org/10.1016/j.sleep.2008.12.006
  5. Clark IA, Vissel B. Inflammation-sleep interface in brain disease: TNF, insulin, orexin. J Neuroinflammation. 2014;11:51.  https://doi.org/10.1186/1742-2094-11-51
  6. Coogan AN, Wyse CA. Neuroimmunology of the circadian clock. Brain Res. 2008;1232:104-112.  https://doi.org/10.1016/j.brainres.2008.07.087
  7. Beynon AL, Coogan AN. Diurnal, age, and immune regulation of interleukin-1β and interleukin-1 type 1 receptor in the mouse suprachiasmatic nucleus. Chronobiol Int. 2010;27:1546-1563. https://doi.org/10.3109/07420528.2010.501927
  8. Sadki A, Bentivoglio M, Kristensson K, Nygård M. Suppressors, receptors and effects of cytokines on the aging mouse biological clock. Neurobiol Aging. 2007;28(2):296-305.  https://doi.org/10.1016/j.neurobiolaging.2005.12.007
  9. Lundkvist GB, Robertson B, Mhlanga JD, Rottenberg ME, Kristensson K. Expression of an oscillating interferon-gamma receptor in the suprachiasmatic nuclei. Neuroreport. 1998;9(6):1059-1063. https://doi.org/10.1097/00001756-199804200-00018
  10. Banisadr G, Fontanges P, Haour F, Kitabgi P, Rostène W, Parsadaniantz SM. Neuroanatomical distribution of CXCR4 in adult rat brain and its localization in cholinergic and dopaminergic neurons. Eur J Neurosci. 2002;16(9):1661-1671. https://doi.org/10.1046/j.1460-9568.2002.02237.x
  11. Guyon A, Banisadr G, Rovère C, et al. Complex effects of stromal cell-derived factor-1 alpha on melanin-concentrating hormone neuron excitability. Eur J Neurosci. 2005;21(3):701-710.  https://doi.org/10.1111/j.1460-9568.2005.03890.x
  12. Hughes PM, Botham MS, Frentzel S, Mir A, Perry VH. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Glia. 2002;37(4):314-327. 
  13. Banisadr G, Quéraud-Lesaux F, Boutterin MC, et al. Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain. J Neurochem. 2002;81(2):257-269.  https://doi.org/10.1046/j.1471-4159.2002.00809.x
  14. Banisadr G, Gosselin RD, Mechighel P, Kitabgi P, Rostène W, Parsadaniantz SM. Highly regionalized neuronal expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) in rat brain: evidence for its colocalization with neurotransmitters and neuropeptides. J Comp Neurol. 2005;489(3):275-292.  https://doi.org/10.1002/cne.20598
  15. Le Thuc O, Cansell C, Bourourou M, et al. Central CCL2 signaling onto MCH neurons mediates metabolic and behavioral adaptation to inflammation. EMBO Rep. 2016;17(12):1738-1752. https://doi.org/10.15252/embr.201541499
  16. Grossberg AJ, Zhu X, Leinninger GM, et al. Inflammation-induced lethargy is mediated by suppression of orexin neuron activity. J Neurosci. 2011;31(31):11376-11386. https://doi.org/10.1523/JNEUROSCI.2311-11.2011
  17. Obukuro K, Nobunaga M, Takigawa M, et al. Nitric oxide mediates selective degeneration of hypothalamic orexin neurons through dysfunction of protein disulfide isomerase. J Neurosci. 2013;33(31):12557-12568. https://doi.org/10.1523/JNEUROSCI.0595-13.2013
  18. Saper CB, Romanovsky AA, Scammell TE. Neural circuitry engaged by prostaglandins during the sickness syndrome. Nat Neurosci. 2012;15(8):1088-1095. https://doi.org/10.1038/nn.3159
  19. Toth LA. Immune-modulatory drugs alter Candida albicans-induced sleep patterns in rabbits. Pharmacol Biochem Behav. 1995;51(4):877-884.  https://doi.org/10.1016/0091-3057(95)00064-4
  20. Toth LA, Krueger JM. Alteration of sleep in rabbits by Staphylococcus aureus infection. Infect Immun. 1988;56(7):1785-1791. https://doi.org/10.1128/IAI.56.7.1785-1791.1988
  21. Toth LA, Gardiner TW, Krueger JM. Modulation of sleep by cortisone in normal and bacterially infected rabbits. Am J Physiol. 1992;263(6 Pt 2):1339-1346. https://doi.org/10.1152/ajpregu.1992.263.6.R1339
  22. Poluektov MG. Sleep and immunity. S.S. Korsakov Journal of Neurology and Psychiatry (Special Issues). 2020;120(9-2):6-12. (In Russ.). https://doi.org/10.17116/jnevro20201200926
  23. Lutters B, Foley P, Koehler PJ. The centennial lesson of encephalitis lethargica. Neurology. 2018;90(12):563-567.  https://doi.org/10.1212/WNL.0000000000005176
  24. Von Economo C. Encephalitis lethargica. Wiener Klin Wochenschr. 1917;30:581-585. 
  25. Triarhou LC. The percipient observations of Constantin von Economo on encephalitis lethargica and sleep disruption and their lasting impact on contemporary sleep research. Brain Research Bulletin. 2006;69(3):244-258.  https://doi.org/10.1016/j.brainresbull.2006.02.002
  26. Gomes M. Encephalitis lethargica epidemic milestones in early sleep neurobiology researches. Sleep Medicine. 2020;74:349-356.  https://doi.org/10.1016/j.sleep.2020.08.019
  27. Lüthy IA, Ritacco V, Kantor IN. A cien años de la gripe «española» [One hundred years after the «Spanish» flu]. Medicina (B Aires). 2018;78(2):113-118. 
  28. Gaeta R, Fornaciari A, Giuffra V. The 1918/19 Spanish Flu in Pisa (Tuscany, Italy): Clinical, Epidemiological and Autoptic Considerations. Acta Medico-Historica Adriatic. 2020;18(1):47-62.  https://doi.org/10.31952/amha.18.1.3
  29. (40) Martini M, Gazzaniga V, Bragazzi NL, Barberis I. The Spanish Influenza Pandemic: a lesson from history 100 years after 1918. Journal of Preventive Medicine and Hygiene. 2019;60(1):64-67.  https://doi.org/10.15167/2421-4248/jpmh2019.60.1.1205
  30. Rajkumar RP. COVID-19 and mental health: A review of the existing literature. Asian Journal of Psychiatry. 2020;52:102066. https://doi.org/10.1016/j.ajp.2020.102066
  31. Huang Y, Zhao N. Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey. Psychiatry Research. 2020;288:112954. https://doi.org/10.1016/j.psychres.2020.112954
  32. Shirshov IuA, Govorin AN. Some peculiarities of the nervous system lesion in flu A/H1N1 in Zabaikale. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(5):53-55. (In Russ.).
  33. Ammar A, Brach M, Trabelsi K, Chtourou H, et.al. Effects of COVID-19 Home Confinement on Eating Behaviour and Physical Activity: Results of the ECLB-COVID19 International Online Survey. Nutrients. 2020;12(6):1583. https://doi.org/10.3390/nu12061583
  34. Altena E, Baglioni C, Espie CA, Ellis J, Gavriloff D, Holzinger B, Schlarb A, Frase L, Jernelöv S, Riemann D. Dealing with sleep problems during home confinement due to the COVID-19 outbreak: Practical recommendations from a task force of the European CBT-I Academy. Journal of Sleep Research. 2020;29(4):e13052. https://doi.org/10.1111/jsr.13052
  35. Leone MJ, Sigman M, Golombek DA. Effects of lockdown on human sleep and chronotype during the COVID-19 pandemic. Current Biology. 2020;30(16):930-931.  https://doi.org/10.1016/j.cub.2020.07.015
  36. Morin CM, Carrier J, Bastien C, Godbout R. Sleep and circadian rhythm in response to the COVID-19 pandemic. Canadian Journal of Public Health. 2020;111(5):654-657.  https://doi.org/10.17269/s41997-020-00382-7
  37. Florea C, Topalidis P, Hauser T, Angerer M, Kurapov A, Leon CB, Brandão DS, Schabus M. Sleep during COVID-19 lockdown: A cross-cultural study investigating job system relevance. Biochemical Pharmacology. 2020;114463. https://doi.org/10.1016/j.bcp.2021.114463
  38. Trakada A, Nikolaidis PT, Dos Santos Andrade M, Puccinelli PJ, Economou NT, Steiropoulos P, Knechtle B, Trakada G. Sleep During «Lockdown» in the COVID-19 Pandemic. International Journal of Environmental research and Public Health. 2020;17(23):9094. https://doi.org/10.3390/ijerph17239094
  39. Kokou-Kpolou CK, Megalakaki O, Laimou D, Kousouri M. Insomnia during COVID-19 pandemic and lockdown: Prevalence, severity, and associated risk factors in French population. Psychiatry Research. 2020;290:113128. https://doi.org/10.1016/j.psychres.2020.113128
  40. Pinto J, van Zeller M, Amorim P, Dantas AP, Eusébio E, Neves A, Pipa J, Clara ES, Santiago T, Viana P, Drummond M. Sleep quality in times of Covid-19 pandemic. Sleep Medicine. 2020;74:81-85.  https://doi.org/10.1016/j.sleep.2020.07.012
  41. Vindegaard N, Benros ME COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain, Behavior, and Immunity. 2020;89:531-542.  https://doi.org/10.1016/j.bbi.2020.05.048
  42. Pérez-Carbonell L, Meurling IJ, Wassermann D, Gnoni V, Leschziner G, Weighall A, Ellis J, Durrant S, Hare A, Steier J. Impact of the novel coronavirus (COVID-19) pandemic on sleep. Journal of Thoracic Disease. 2020;12(suppl 2):163-175.  https://doi.org/10.21037/jtd-cus-2020-015
  43. Mazza MG, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, Melloni EMT, Furlan R, Ciceri F, Rovere-Querini P. COVID-19 BioB Outpatient Clinic Study group, Benedetti F. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain, Behavior, and Immunity. 2020;89:594-600.  https://doi.org/10.1016/j.bbi.2020.07.037
  44. Öztürk G, Akbulut KG, Güney. Melatonin, aging, and COVID-19: Could melatonin be beneficial for COVID-19 treatment in the elderly? Turk J Med Sci. 2020;50(6):1504-1512. https://doi.org/10.3906/sag-2005-356
  45. Zhang R, Wang X, Ni L, Di X, Ma B, Niu S, Liu C, Reiter RJ. Melatonin as a potential adjuvant treatment COVID-19. Life Sci. 2020;250:117583. https://doi.org/10.1016/j.lfs.2020.117583
  46. Juybari KB, Pourhanifeh MH, Hosseinzadeh A, Hemati K, Mehrzadi S. Melatonin potentials against viral infections including COVID-19: Current evidence and new findings. Virus Res. 2020;287:198108. https://doi.org/10.1016/j.virusres.2020.198108
  47. El-Missiry MA, El-Missiry ZMA, Othman AI. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19. Eur J Pharmacol. 2020;882:173329. https://doi.org/10.1016/j.ejphar.2020.173329
  48. Heideman R, Bhatnagar K, Hilton F, Bronson F. Melatonin rhythms and pineal structure in a tropical bat, Anoura geoffroyi, that does not use photoperiod to regulate seasonal reproduction. J Pineal Res. 1996;20(2):90-97. 
  49. Tresguerres M, Parks SK, Goss GG, V-H+-ATPase, Na+/K+-ATPase and NHE2 immunoreactivity in the gill epithelium of the Pacific hagfish (Epatretus stoutii). Comp. Biochem. Physiol., Part A Mol. Integr. Physiol. 2006;145(3):312-321. 
  50. Anderson G, Reiter RJ. Melatonin: Roles in influenza, Covid-19, and other viral infections. Rev Med Virol. 2020;30(3):e2109. https://doi.org/10.1002/rmv.2109
  51. Shneider A, Kudriavtsev A, Vakhrusheva A. Can melatonin reduce the severity of COVID-19 pandemic? Int Rev Immunol. 2020;39(4):153-162.  https://doi.org/10.1080/08830185.2020.1756284
  52. Russel JR, Abreu-Gonzalez P, Marik PE, Dominguez-Rodriguez A. Therapeutic Algorithm for Use of Melatonin in Patients With COVID-19. Front Med (Lausanne). 2020;7:226.  https://doi.org/10.3389/fmed.2020.00226
  53. Giménez VMM, Inserra F, Tajer CD, Ferder JML, Reiter RJ, Manucha W. Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment. Life Sci. 2020;254:117808. https://doi.org/10.1016/j.lfs.2020.117808
  54. State Register of Medicines of the Ministry of Health of the Russian Federation (Electronic resource). Access date 26.02.2021. (In Russ.). https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=b196cea9-684a-49ab-9ccc-33475d778015&t=
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.